Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 383-398

  Li, Wei ^a,b   Ain, Kenneth B ^a,b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BUTYRIC ACID; LUCIFERASE; MESSENGER RNA; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REPRESSOR PROTEIN; SODIUM IODIDE SYMPORTER; SODIUM IODIDE SYMPORTER REPRESSOR PROTEIN; THYROID TRANSCRIPTION FACTOR 2; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; BINDING SITE; CANCER CELL; CONTROLLED STUDY; CROSS LINKING; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; SEQUENCE HOMOLOGY; THYROID CARCINOMA; THYROID CELL;

CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, LIQUID; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; TANDEM MASS SPECTROMETRY; THYROID GLAND;

EID: 77953606626     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0156     Document Type: Article

References (24)

1. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C & Endres M 2001 Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. International Journal of Molecular Medicine 7 255-260.
2. Ain KB 2000 Management of undifferentiated thyroid cancer. Bailliere's Best Practice and Research. Clinical Endocrinology and Metabolism 14 615-629.
3. Ain KB & Taylor KD 1994 Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. Journal of Clinical Endocrinology and Metabolism 78 1097-1102.
4. Ain KB, Taylor KD, Banks ER & Pettigrew AL 1992 Characterization of an immortalized cell-line (KAK-1) from a benign human thyroid follicular adenoma. Thyroid 2 S49.
5. Ausubel FM 1995 Short Protocols in Molecular Biology: A Compendium of Methods From Current Protocols in Molecular Biology. New York: Wiley.
6. Chiba-Falek O, Kowalak JA, Smulson ME & Nussbaum RL 2005 Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. American Journal of Human Genetics 76 478-492.
7. Gadgil H, Jurado LA & Jarrett HW 2001 DNA affinity chromatography of transcription factors. Analytical Biochemistry 290 147-178.
8. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M & Kraus WL 2008 Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319 819-821.
9. Li W, Venkataraman GM & Ain KB 2007 Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor. Journal of Clinical Endocrinology and Metabolism 92 1080-1087.
10. Miyamoto T, Kakizawa T & Hashizume K 1999 Inhibition of nuclear receptor signaling by poly(ADP-ribose) polymerase. Molecular and Cellular Biology 19 2644-2649. (Pubitemid 29144508)
11. Pasca di Magliano M, Di Lauro R & Zannini M 2000 Pax8 has a key role in thyroid cell differentiation. PNAS 97 13144-13149.
12. Petrich T, Helmeke HJ, Meyer GJ, Knapp WH & Potter E 2002 Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. European Journal of Nuclear Medicine and Molecular Imaging 29 842-854.
13. Pohlenz J & Refetoff S 1999 Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. Biochimie 81 469-476.
14. Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S & Costagliola S 2000 Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. Journal of Clinical Endocrinology and Metabolism 85 2366-2369.
15. Presta I, Arturi F, Ferretti E, Mattei T, Scarpelli D, Tosi E, Scipioni A, Celano M, Gulino A, Filetti S et al. 2005 Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene. BMC Cancer 5 80.
16. Riedel C, Levy O & Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. Journal of Biological Chemistry 276 21458-21463.
17. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA & Reynolds J 1991 Thyroid cancer: a lethal endocrine neoplasm. Annals of Internal Medicine 115 133-147.
18. Schmitt TL, Espinoza CR & Loos U 2001 Transcriptional regulation of the human sodium/iodide symporter gene by Pax8 and TTF-1. Experimental and Clinical Endocrinology and Diabetes 109 27-31.
19. Schreiber V, Dantzer F, Ame JC & de Murcia G 2006 Poly(ADP-ribose): novel functions for an old molecule. Nature Reviews. Molecular Cell Biology 7 517-528.
20. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC et al. 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. Journal of Clinical Endocrinology and Metabolism 93 4331-4341.
21. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, Hassa PO, Hottiger MO & Smulson ME 2003 PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 22 8460-8471.
22. - symporter gene methylation status. Journal of Clinical Endocrinology and Metabolism 84 2449-2457.
23. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O & Carrasco N 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. Journal of Clinical Endocrinology and Metabolism 88 1880-1888.
24. Zhang Z, Hildebrandt EF, Simbulan-Rosenthal CM & Anderson MG 2002 Sequence-specific binding of poly (ADP-ribose) polymerase-1 to the human T cell leukemia virus type-I tax responsive element. Virology 296 107-116.